Advanced analytics for the highest demands
Precision and innovation in drug analysis
In the pharmaceutical industry, SAS Hagmann offers specialized analytical services that are crucial for the development and quality assurance of medications. Our portfolio includes active ingredient analysis, stability testing, and purity controls to ensure the efficacy, safety, and purity of pharmaceutical products.
Using state-of-the-art technologies and in-depth expertise, we assist our clients in meeting stringent regulatory requirements and maintaining the highest quality standards.
About SAS hagmann: Pioneers in analytical chemistry
Since our founding in 1996, SAS hagmann has established itself as an independent, family-run contract laboratory for analytical chemistry.
Our goal is your satisfaction. We support you with our many years of experience in quality control, validation and monitoring of processes as well as the analysis of residues on implants and the identification of contamination on surfaces. Our team of experts helps you to meet the high quality requirements in industries such as automotive, aviation, pharmaceuticals and medical technology.
At SAS hagmann, the passion for chemical analysis is at the heart of our work.
Key procedures
at a glance
Active Ingredient Analysis
SAS hagmann supports clients in conducting Environmental Risk Assessments (ERA) as required for the approval processes of pharmaceuticals according to the European Medicines Agency (EMA) standards. A registration dossier for the market authorization of human medicinal products (HMP) must mandatorily include an ERA, which evaluates the intended use in the dosage form, the physicochemical and ecotoxicological properties, and the environmental behavior of the active ingredient.
The necessary risk assessment is divided into phases, during which chemical and biological analyses are conducted according to widely recognized OECD protocols.
In addition to sampling the actual pharmaceutical active ingredients (API), SAS Hagmann assists clients in implementing risk management measures such as ICH Q3, which aim to evaluate the entire pharmaceutical product, including not only the active ingredients but also excipients, precursor compounds, and other process-involved reagents.
Our
contact persons
Contact us, and we will help you find the information you need and provide you with customized solutions for your specific requirements.
Pharmaceutical
Selina Steinhilber
M.Sc. Biomedical Sciences
- QMB
- Project Manager Medical Products
Every question is the first step towards a new solution.
We are just a click away to answer your questions and provide you with our expertise. Fill out the contact form, and a member of our team will promptly get in touch with you. At SAS Hagmann, we are ready to listen and collaborate on solutions that truly make a difference.
